DrugWiki
Full FDA database info
About
Access comprehensive drug information directly from the FDA database. Search by brand name, ingredient, or keyword to find details on drug interactions, usage, ingredients, and more. Ideal for students and scientists needing reliable medical data.
What's New in DrugWiki
2.2
June 8, 2019
bug fixes
In-App Purchases
$4.99
Drug Wiki
In-app purchase to remove ads
Developer apps
FAQ
What kind of drug information does DrugWiki provide?
DrugWiki provides comprehensive medical drug information sourced from the FDA database. This includes drug names, manufacturers, ingredients, medical history, interactions, precautions, clinical information, pharmacokinetics, indications, dosage, and more.
How can I search for drugs in DrugWiki?
You can search for drugs in DrugWiki by brand name, drug ingredients, or any other relevant keyword. The app allows for flexible searching to help you find the information you need quickly.
Is DrugWiki suitable for medical professionals or students?
Yes, DrugWiki is particularly useful for students and scientists who require detailed and reliable medical drug information. It offers a complete list of parameters for each drug, aiding in research and study.
What devices is DrugWiki available on?
DrugWiki is available on iPhone, iPad, and iPod. It is designed to provide easy access to drug information across these Apple devices.
What is the age rating for DrugWiki?
The age rating for DrugWiki is 12+. This indicates that the content is generally suitable for users aged 12 and older.
How often is DrugWiki updated?
The latest version of DrugWiki is 2.2, and it was last updated on June 8, 2019. While the app has not been updated recently, it draws from the continuously updated FDA database.
Does DrugWiki have ads?
No, DrugWiki does not contain advertisements. The app is free to download and use, with potential for in-app purchases.
What is the user rating for DrugWiki?
DrugWiki has a perfect rating of 5.0 stars based on 3 user ratings. This suggests a very positive user experience among its current reviewers.
